Burning Rock Biotech Limited (BNR)
USD 2.88
(3.42%)
USD 2.88
(3.42%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 363.22 Million CNY | -4.42% |
| 2022 | 380.03 Million CNY | 4.36% |
| 2021 | 364.14 Million CNY | 16.0% |
| 2020 | 313.92 Million CNY | 14.85% |
| 2019 | 273.33 Million CNY | 102.38% |
| 2018 | 135.05 Million CNY | 88.38% |
| 2017 | 71.69 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 85.69 Million CNY | 9.71% |
| 2024 Q2 | 95.43 Million CNY | 11.37% |
| 2023 Q3 | 85.92 Million CNY | -14.44% |
| 2023 Q1 | 98.77 Million CNY | -2.46% |
| 2023 Q2 | 100.42 Million CNY | 1.67% |
| 2023 FY | 363.22 Million CNY | -4.42% |
| 2023 Q4 | 78.11 Million CNY | -9.09% |
| 2022 Q4 | 101.26 Million CNY | -6.75% |
| 2022 Q3 | 108.59 Million CNY | 31.47% |
| 2022 Q2 | 82.6 Million CNY | -5.68% |
| 2022 FY | 380.03 Million CNY | 4.36% |
| 2022 Q1 | 87.58 Million CNY | -16.89% |
| 2021 FY | 364.14 Million CNY | 16.0% |
| 2021 Q4 | 105.37 Million CNY | 15.05% |
| 2021 Q3 | 91.59 Million CNY | 1.51% |
| 2021 Q2 | 90.23 Million CNY | 17.27% |
| 2021 Q1 | 76.94 Million CNY | -22.4% |
| 2020 Q2 | 78.39 Million CNY | 75.06% |
| 2020 FY | 313.92 Million CNY | 14.85% |
| 2020 Q1 | 44.78 Million CNY | -18.54% |
| 2020 Q4 | 99.15 Million CNY | 8.26% |
| 2020 Q3 | 91.58 Million CNY | 16.82% |
| 2019 Q2 | 62.05 Million CNY | -20.55% |
| 2019 Q4 | 54.97 Million CNY | -29.69% |
| 2019 Q3 | 78.18 Million CNY | 25.99% |
| 2019 Q1 | 78.11 Million CNY | 74.43% |
| 2019 FY | 273.33 Million CNY | 102.38% |
| 2018 FY | 135.05 Million CNY | 88.38% |
| 2018 Q4 | 44.78 Million CNY | 0.0% |
| 2017 FY | 71.69 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 13.16 Million USD | -2658.407% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -6464.226% |
| Aspira Women's Health Inc. | 5.26 Million USD | -6802.832% |
| Biodesix, Inc. | 36.07 Million USD | -906.81% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -27220.613% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -45784.3% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -45784.3% |
| Bionano Genomics, Inc. | 9.56 Million USD | -3697.063% |
| CareDx, Inc | 178.32 Million USD | -103.688% |
| Check-Cap Ltd. | -212 Thousand USD | 171433.491% |
| Castle Biosciences, Inc. | 174.8 Million USD | -107.789% |
| DarioHealth Corp. | 5.98 Million USD | -5969.97% |
| Exact Sciences Corporation | 1.84 Billion USD | 80.318% |
| Fulgent Genetics, Inc. | 104.45 Million USD | -247.732% |
| Guardant Health, Inc. | 336.89 Million USD | -7.816% |
| ICON Public Limited Company | 1.81 Billion USD | 79.98% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 83.414% |
| Illumina, Inc. | 2.74 Billion USD | 86.763% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -25378.421% |
| iSpecimen Inc. | 5.1 Million USD | -7011.061% |
| Standard BioTools Inc. | 50.45 Million USD | -619.974% |
| MDxHealth SA | 43.92 Million USD | -726.85% |
| 23andMe Holding Co. | 99.37 Million USD | -265.504% |
| Medpace Holdings, Inc. | 524.5 Million USD | 30.749% |
| Myriad Genetics, Inc. | 476.4 Million USD | 23.756% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -71168.633% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 131966.285% |
| NeoGenomics, Inc. | 244.6 Million USD | -48.496% |
| Neogen Corporation | 463.9 Million USD | 21.701% |
| Inotiv, Inc. | 165.44 Million USD | -119.548% |
| Natera, Inc. | 492.74 Million USD | 26.284% |
| OpGen, Inc. | -90.69 Thousand USD | 400597.277% |
| OPKO Health, Inc. | 318.12 Million USD | -14.177% |
| Psychemedics Corporation | 8.41 Million USD | -4217.449% |
| Prenetics Global Limited | 8.82 Million USD | -4013.609% |
| Prenetics Global Limited | 8.82 Million USD | -4013.609% |
| Precipio, Inc. | 6.01 Million USD | -5935.676% |
| Personalis, Inc. | 18.2 Million USD | -1894.876% |
| RadNet, Inc. | 93 Million USD | -290.567% |
| Sera Prognostics, Inc. | 96 Thousand USD | -378261.458% |
| Sotera Health Company | 577.15 Million USD | 37.066% |
| Neuronetics, Inc. | 51.7 Million USD | -602.499% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -2945.673% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -2945.673% |
| Trinity Biotech plc | 19.45 Million USD | -1767.491% |
| T2 Biosystems, Inc. | -8.17 Million USD | 4545.863% |
| Twist Bioscience Corporation | 133.34 Million USD | -172.388% |
| Exagen Inc. | 29.45 Million USD | -1133.117% |